Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol Randomized Withdrawal in Hypertension
NCT00785512Phase 4Completed
- Sponsor
- Forest Laboratories
- Start
- Nov 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypertension (HTN) comparing Nebivolol with Placebo (2 arms). Primary endpoint: Trough Sitting Diastolic Blood Pressure at Week 4. Started Nov 2008; status: completed.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00785512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00785512.